Vesicular stomatitis virus-based vaccines protect nonhuman primates against aerosol challenge with Ebola and Marburg viruses
- 9 December 2008
- journal article
- Published by Elsevier BV in Vaccine
- Vol. 26 (52), 6894-6900
- https://doi.org/10.1016/j.vaccine.2008.09.082
Abstract
No abstract availableKeywords
This publication has 36 references indexed in Scilit:
- Recombinant Vesicular Stomatitis Virus Vector Mediates Postexposure Protection against Sudan Ebola Hemorrhagic Fever in Nonhuman PrimatesJournal of Virology, 2008
- Vaccine To Confer to Nonhuman Primates Complete Protection against Multistrain Ebola and Marburg Virus InfectionsClinical and Vaccine Immunology, 2008
- Marburg Virus Infection Detected in a Common African BatPLOS ONE, 2007
- Successful Topical Respiratory Tract Immunization of Primates against Ebola VirusJournal of Virology, 2007
- Neutralizing Antibody Fails to Impact the Course of Ebola Virus Infection in MonkeysPLoS Pathogens, 2007
- Effective Post-Exposure Treatment of Ebola InfectionPLoS Pathogens, 2007
- Cross-Protection against Marburg Virus Strains by Using a Live, Attenuated Recombinant VaccineJournal of Virology, 2006
- Immune Protection of Nonhuman Primates against Ebola Virus with Single Low-Dose Adenovirus Vectors Encoding Modified GPsPLoS Medicine, 2006
- Pathogenesis of Ebola Hemorrhagic Fever in Cynomolgus Macaques: Evidence that Dendritic Cells Are Early and Sustained Targets of InfectionThe American Journal of Pathology, 2003
- Accelerated vaccination for Ebola virus haemorrhagic fever in non-human primatesNature, 2003